Cardiomyopathies are traditionally classified by structural and genetic phenotypes, but emerging evidence highlights chronic myocardial inflammation as a pivotal driver of disease progression across different etiologies. This review synthesizes the current literature on the cellular and molecular inflammatory mechanisms underlying hypertrophic cardiomyopathy, Anderson–Fabry disease, cardiac amyloidosis, arrhythmogenic cardiomyopathy, and dilated cardiomyopathy. Across these distinct conditions, endogenous triggers such as metabolic substrates, misfolded amyloid fibrils, mechanical stress, or viral genomes act as damage-associated molecular patterns. These stimuli activate innate and adaptive immune cascades, notably the Toll-like receptors, the NF-κB pathway, and the NLRP3 inflammasome. This immune activation establishes a pro-inflammatory microenvironment that promotes fibroblast reprogramming, myocardial edema, and progressive fibrotic or fibro-fatty remodeling. Inflammation is an active, core pathophysiological mechanism rather than a passive secondary bystander in cardiomyopathies. Recognizing these shared immune pathways provides a framework for improved risk stratification and highlights the potential for targeted immunomodulatory therapies to alter disease trajectories.

Inflammation in Cardiomyopathies: Cellular Mechanisms Across Cardiac Phenotype / Lattanzio, A., Marchionni, G., Pecci, G., Ciccarelli, F., Stavagna, S., Costantino, J., Ballatore, F., Alfarano, M., Ciciarello, F., Chimenti, C.. - In: CELLS. - ISSN 2073-4409. - 15:12(2026). [10.3390/cells15121131]

Inflammation in Cardiomyopathies: Cellular Mechanisms Across Cardiac Phenotype

Antonio Lattanzio;Giulia Pecci;Federico Ciccarelli;Silvia Stavagna;Jacopo Costantino;Federico Ballatore;Maria Alfarano;Francesco Ciciarello;Cristina Chimenti
2026

Abstract

Cardiomyopathies are traditionally classified by structural and genetic phenotypes, but emerging evidence highlights chronic myocardial inflammation as a pivotal driver of disease progression across different etiologies. This review synthesizes the current literature on the cellular and molecular inflammatory mechanisms underlying hypertrophic cardiomyopathy, Anderson–Fabry disease, cardiac amyloidosis, arrhythmogenic cardiomyopathy, and dilated cardiomyopathy. Across these distinct conditions, endogenous triggers such as metabolic substrates, misfolded amyloid fibrils, mechanical stress, or viral genomes act as damage-associated molecular patterns. These stimuli activate innate and adaptive immune cascades, notably the Toll-like receptors, the NF-κB pathway, and the NLRP3 inflammasome. This immune activation establishes a pro-inflammatory microenvironment that promotes fibroblast reprogramming, myocardial edema, and progressive fibrotic or fibro-fatty remodeling. Inflammation is an active, core pathophysiological mechanism rather than a passive secondary bystander in cardiomyopathies. Recognizing these shared immune pathways provides a framework for improved risk stratification and highlights the potential for targeted immunomodulatory therapies to alter disease trajectories.
2026
Anderson–Fabry disease; arrhythmogenic cardiomyopathy; cardiac amyloidosis; cardiomyopathies; dilated cardiomyopathy; hypertrophic cardiomyopathy; innate immunity; myocardial fibrosis; myocardial inflammation
01 Pubblicazione su rivista::01a Articolo in rivista
Inflammation in Cardiomyopathies: Cellular Mechanisms Across Cardiac Phenotype / Lattanzio, A., Marchionni, G., Pecci, G., Ciccarelli, F., Stavagna, S., Costantino, J., Ballatore, F., Alfarano, M., Ciciarello, F., Chimenti, C.. - In: CELLS. - ISSN 2073-4409. - 15:12(2026). [10.3390/cells15121131]
File allegati a questo prodotto
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1779371
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 0
  • ???jsp.display-item.citation.isi??? 0
social impact